Abstract
Objective: We aimed to investigate the current practice patterns of permanent pacing, especially the timing of implantation, for high-degree AV block (HDAVB) following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). Background: Comparative data regarding current practice patterns of permanent pacing for HDAVB between TAVI and SAVR is limited. Methods: Using the National Inpatient Sample database, we identified patients who underwent TAVI or SAVR between 2012 and 2014. The incidence of HDAVB, the rate of permanent pacemaker implantation, and the timing of implantations were compared between TAVI and SAVR groups. Results: We identified 33 690 and 202 110 patients who underwent TAVI and SAVR, respectively. HDAVB occurred in 3480 patients (10.3%) in the TAVI group and 11 405 patients (5.6%) in the SAVR group (P < 0.001). Among the patients who developed HDAVB, patients in the TAVI group were more likely to undergo permanent pacemaker implantation than those in the SAVR group (74.1% vs 64.7%; P < 0.001). The median interval from TAVI to pacemaker implantation was 2 days (interquartile range 1-3 days) vs 5 days (interquartile range 3-7 days) from SAVR to pacemaker implantation (P < 0.001). Among the patients who developed HDAVB, TAVI was associated with higher rates of permanent pacemaker implantation after adjusting for other comorbidities (odds ratio 1.41:95% confidence interval 1.13-1.77; P = 0.003). Conclusions: HDAVB occurred more commonly after TAVI compared to SAVR. HDAVB after TAVI compared to SAVR was associated with a higher rate of permanent pacemaker implantation at an earlier timing from the index procedure.
Original language | English |
---|---|
Pages (from-to) | E385-E390 |
Journal | Catheterization and Cardiovascular Interventions |
Volume | 93 |
Issue number | 7 |
DOIs | |
State | Published - Jun 1 2019 |
Bibliographical note
Publisher Copyright:© 2018 Wiley Periodicals, Inc.
Funding
information Penny Warren Research Award from the University of Kentucky (Lexington, Kentucky, United States).; University of Kentucky Clinical and Translational Science Pilot Award, Grant/Award Number: UL1TR000117; UK COBRE Early Career Program, Grant/Award Number: P20 GM103527; National Institutes of Health (NIH), Grant/Award Number: R56 HL124266This work was supported by the Penny Warren Research Award from the University of Kentucky (Lexington, Kentucky, United States). Dr. Abdel-Latif is supported by the University of Kentucky Clinical and Translational Science Pilot Award (UL1TR000117), the UK COBRE Early Career Program (P20 GM103527) and the NIH Grant R56 HL124266. Dr. Abdel-Latif is supported by the University of Kentucky Clinical and Translational Science Pilot Award (UL1TR000117), the UK COBRE Early Career Program (P20 GM103527) and the NIH Grant R56 HL124266. Penny Warren Research Award from the University of Kentucky (Lexington, Kentucky, United States).; University of Kentucky Clinical and Translational Science Pilot Award, Grant/ Award Number: UL1TR000117; UK COBRE Early Career Program, Grant/Award Number: P20 GM103527; National Institutes of Health (NIH), Grant/Award Number: R56 HL124266
Funders | Funder number |
---|---|
Corporacion Nacional del Cobre | P20 GM103527 |
National Institutes of Health (NIH) | R56 HL124266 |
National Institute of General Medical Sciences | P30GM127211 |
University of Kentucky | |
University of Kentucky, Center for Clinical and Translational Science | UL1TR000117 |
Keywords
- AVD - aortic valve disease
- SVAL – surgery, vavular
- TVI – transcatheter valve implantation
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine